Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor

Nucleic Acids Research

Volumn 44, Issue 2, 2016, Pages 636-647

  Matsuda, Shun ^a   Adachi, Jun ^b   Ihara, Masaru ^a   Tanuma, Nobuhiro ^c   Shima, Hiroshi ^c   Kakizuka, Akira ^d   Ikura, Masae ^e   Ikura, Tsuyoshi ^e   Matsuda, Tomonari ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ARYLHYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE H3; LYSINE; PHOSPHOENOLPYRUVATE; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE KINASE; PYRUVATE KINASE M2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; AROMATIC HYDROCARBON RECEPTOR; AUTOANTIGEN; CARRIER PROTEIN; CHROMATIN; CYP1A1 PROTEIN, HUMAN; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; DLAT PROTEIN, HUMAN; HISTONE; HISTONE ACETYLTRANSFERASE PCAF; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; P300-CBP-ASSOCIATED FACTOR; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS;

ARTICLE; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; ENHANCER REGION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; XENOBIOTIC METABOLISM; ACETYLATION; GENETICS; HELA CELL LINE; METABOLISM;

ACETYLATION; AUTOANTIGENS; CARRIER PROTEINS; CHROMATIN; CYTOCHROME P-450 CYP1A1; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; ENHANCER ELEMENTS, GENETIC; HELA CELLS; HISTONES; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; P300-CBP TRANSCRIPTION FACTORS; RECEPTORS, ARYL HYDROCARBON; THYROID HORMONES; TRANSCRIPTIONAL ACTIVATION;

EID: 84966264074     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv967     Document Type: Article

References (38)

1. Zentner,G.E. and Henikoff,S. (2013) Regulation of nucleosome dynamics by histone modifications. Nat. Struct. Mol. Biol., 20, 259-266.
2. Wellen,K.E., Hatzivassiliou,G., Sachdeva,U.M., Bui,T.V., Cross,J.R. and Thompson,C.B. (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science, 324, 1076-1080.
3. Takahashi,H., McCaffery,J.M., Irizarry,R.A. and Boeke,J.D. (2006) Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Mol. Cell, 23, 207-217.
4. Sutendra,G., Kinnaird,A., Dromparis,P., Paulin,R., Stenson,T.H., Haromy,A., Hashimoto,K., Zhang,N., Flaim,E. and Michelakis,E.D. (2014) A nuclear pyruvate dehydrogenase complex is important for the generation of Acetyl-CoA and histone acetylation. Cell, 158, 84-97.
5. Gao,X., Wang,H., Yang,J.J., Liu,X. and Liu,Z.R. (2012) Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell, 45, 598-609.
6. Lee,J., Kim,H.K., Han,Y.M. and Kim,J. (2008) Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Int. J. Biochem. Cell Biol., 40, 1043-1054.
7. Luo,W., Hu,H., Chang,R., Zhong,J., Knabel,M., O'Meally,R., Cole,R.N., Pandey,A. and Semenza,G.L. (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell, 145, 732-744.
8. Yang,W., Xia,Y., Ji,H., Zheng,Y., Liang,J., Huang,W., Gao,X., Aldape,K. and Lu,Z. (2011) Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature, 480, 118-122.
9. Yang,W., Xia,Y., Hawke,D., Li,X., Liang,J., Xing,D., Aldape,K., Hunter,T., Yung,W.K. and Lu,Z. (2012) PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell, 150, 685-696.
10. Chueh,F.Y., Leong,K.F., Cronk,R.J., Venkitachalam,S., Pabich,S. and Yu,C.L. (2011) Nuclear localization of pyruvate dehydrogenase complex-E2 (PDC-E2), a mitochondrial enzyme, and its role in signal transducer and activator of transcription 5 (STAT5)-dependent gene transcription. Cell Signal., 23, 1170-1178.
11. Nebert,D.W., Roe,A.L., Dieter,M.Z., Solis,W.A., Yang,Y. and Dalton,T.P. (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol., 59, 65-85.
12. Yusufzai,T.M., Tagami,H., Nakatani,Y. and Felsenfeld,G. (2004) CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species. Mol. Cell, 13, 291-298.
13. Christofk,H.R., Vander Heiden,M.G., Harris,M.H., Ramanathan,A., Gerszten,R.E., Wei,R., Fleming,M.D., Schreiber,S.L. and Cantley,L.C. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature, 452, 230-233.
14. Hinman,L.M. and Blass,J.P. (1981) An NADH-linked spectrophotometric assay for pyruvate dehydrogenase complex in crude tissue homogenates. J. Biol. Chem., 256, 6583-6586.
15. Nakamura,T., Pluskal,T., Nakaseko,Y. and Yanagida,M. (2012) Impaired coenzyme A synthesis in fission yeast causes defective mitosis, quiescence-exit failure, histone hypoacetylation and fragile DNA. Open Biol., 2, 120117.
16. Adachi,J., Mori,Y., Matsui,S., Takigami,H., Fujino,J., Kitagawa,H., Miller,C.A. 3rd, Kato,T., Saeki,K. and Matsuda,T. (2001) Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem., 276, 31475-31478.
17. Mazurek,S., Boschek,C.B., Hugo,F. and Eigenbrodt,E. (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin. Cancer Biol., 15, 300-308.
18. Thangaraju,M., Carswell,K.N., Prasad,P.D. and Ganapathy,V. (2009) Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem. J., 417, 379-389.
19. Garrison,P.M., Rogers,J.M., Brackney,W.R. and Denison,M.S. (2000) Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. Arch. Biochem. Biophys., 374, 161-171.
20. Kobayashi,A., Numayama-Tsuruta,K., Sogawa,K. and Fujii-Kuriyama,Y. (1997) CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J. Biochem., 122, 703-710.
21. Le Mellay,V., Houben,R., Troppmair,J., Hagemann,C., Mazurek,S., Frey,U., Beigel,J., Weber,C., Benz,R., Eigenbrodt,E. et al. (2002) Regulation of glycolysis by Raf protein serine/threonine kinases. Adv. Enzyme Regul., 42, 317-332.
22. Noguchi,T., Inoue,H. and Tanaka,T. (1986) The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J. Biol. Chem., 261, 13807-13812.
23. Choi,Y.S., Hoon Jeong,J., Min,H.K., Jung,H.J., Hwang,D., Lee,S.W. and Kim Pak,Y. (2011) Shot-gun proteomic analysis of mitochondrial D-loop DNA binding proteins: identification of mitochondrial histones. Mol. Biosyst., 7, 1523-1536.
24. Zanin,M.K., Donohue,J.M. and Everitt,B.A. (2010) Evidence that core histone H3 is targeted to the mitochondria in Brassica oleracea. Cell Biol. Int., 34, 997-1003.
25. Bjeldanes,L.F., Kim,J.Y., Grose,K.R., Bartholomew,J.C. and Bradfield,C.A. (1991) Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. U.S.A., 88, 9543-9547.
26. Rannug,U., Rannug,A., Sjoberg,U., Li,H., Westerholm,R. and Bergman,J. (1995) Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem. Biol., 2, 841-845.
27. Hoessel,R., Leclerc,S., Endicott,J.A., Nobel,M.E., Lawrie,A., Tunnah,P., Leost,M., Damiens,E., Marie,D., Marko,D. et al. (1999) Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol., 1, 60-67.
28. Adachi,J., Mori,Y., Matsui,S. and Matsuda,T. (2004) Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicol. Sci., 80, 161-169.
29. Hacker,H.J., Steinberg,P. and Bannasch,P. (1998) Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis, 19, 99-107.
30. Harada,Y., Nakamura,M. and Asano,A. (1995) Temporally distinctive changes of alternative splicing patterns during myogenic differentiation of C2C12 cells. J. Biochem., 118, 780-790.
31. Izumi,S., Manabe,A., Tomoyasu,A., Kihara-Negishi,F. and Ariga,H. (1995) Molecular cloning of the complementary DNA for the mouse pyruvate kinase M-2 gene whose expression is dependent upon cell differentiation. Biochim. Biophys. Acta, 1267, 135-138.
32. Scott,R.J., English,V., Noguchi,T., Tanaka,T. and Yeoh,G.C. (1988) Pyruvate kinase isoenzyme transitions in cultures of fetal rat hepatocytes. Cell Differ. Dev., 25, 109-118.
33. Poland,A. and Knutson,J.C. (1982) 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol., 22, 517-554.
34. Safe,S. (1990) Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol., 21, 51-88.
35. Couture,L.A., Abbott,B.D. and Birnbaum,L.S. (1990) A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology, 42, 619-627.
36. Mimura,J., Yamashita,K., Nakamura,K., Morita,M., Takagi,T.N., Nakao,K., Ema,M., Sogawa,K., Yasuda,M., Katsuki,M. et al. (1997) Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells, 2, 645-654.
37. Peters,J.M., Narotsky,M.G., Elizondo,G., Fernandez-Salguero,P.M., Gonzalez,F.J. and Abbott,B.D. (1999) Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor (AhR)-null mice. Toxicol. Sci., 47, 86-92.
38. Jin,U.H., Lee,S.O. and Safe,S. (2012) Aryl hydrocarbon receptor (AHR)-active pharmaceuticals are selective AHR modulators in MDA-MB-468 and BT474 breast cancer cells. J. Pharmacol. Exp. Ther., 343, 333-341.